ACCOUNTS - Final Accounts

NIMROD LIFE SCIENCES LIMITED - Company Information

Print Friendly Version

Registered number: 02543120

NIMROD LIFE SCIENCES LIMITED

UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2019

NIMROD LIFE SCIENCES LIMITED

REGISTERED NUMBER: 02543120

BALANCE SHEET

AS AT 30 SEPTEMBER 2019

		2019		2018
Note		£		£

FIXED ASSETS
Investments	4		243,418		243,418
CURRENT ASSETS
Debtors: amounts falling due within one year	5	10,120		-
Cash at bank		892,295		943,863
Creditors: amounts falling due within one year	6	(1,596)		(1,500)
NET CURRENT ASSETS			900,819		942,363

NET ASSETS			1,144,237		1,185,781

CAPITAL AND RESERVES
Called up share capital	7	8	8
Share premium account		109,409	109,409
Profit and loss account		1,034,820	1,076,364
		1,144,237	1,185,781

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

Mr M J M Rawe	Mr S J Lawrence
Director	Director

Date: 17 April 2020

The notes on pages 2 to 4 form part of these financial statements.

Page 1

NIMROD LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2019

1.	GENERAL INFORMATION

Nimrod Life Sciences Limited limited by shares and incorporated in England and Wales. Its registered office is Unit 1, Priors Hall, Widdington, Saffron Walden, Essex, CB11 3SB. The company's functional and presentational currency is GBP and the figures in these financial statements are rounded to the nearest pound.

2.ACCOUNTING POLICIES

2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

2.2

VALUATION OF INVESTMENTS

Investments in subsidiaries are measured at cost less accumulated impairment.

2.3

DEBTORS

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

2.4

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

2.5

CREDITORS

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

2.6

PENSIONS

The company contributes to the personal pension plans of the directors.
The contributions are recognised as an expense in the Profit and Loss Account when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of these plans are held separately from the Company in independently administered funds.

Page 2

NIMROD LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2019

2.ACCOUNTING POLICIES (CONTINUED)

2.7

TAXATION

Tax is recognised in the Profit and Loss Account, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

3.	EMPLOYEES
	The Company has no employees other than the directors, who received contributions into their personal pension plans totalling £50,000 (2018 - £NIL).

4.	FIXED ASSET INVESTMENTS

		Investments in subsidiary companies
		£
	COST
	At 1 October 2018	243,418
	At 30 September 2019	243,418

DEBTORS

					2019	2018
					£	£


Amounts owed by group undertakings	10,120	-

6.	CREDITORS: Amounts falling due within one year
		2019	2018
		£	£

Accruals and deferred income	1,596	1,500
	1,596	1,500

Page 3

NIMROD LIFE SCIENCES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2019

7.	SHARE CAPITAL
		2019	2018
		£	£

Allotted, called up and fully paid

8 (2018 - 8) Ordinary shares of £1.00 each	8	8

Page 4